How is AI transforming the future of cancer diagnosis

The synergy of human and AI-based insights in cancer pathology can open avenues for early cancer detection for better patient-specific assessment and treatment.

E27 Article by Dr. Rajasa Jialdasani, Chief Medical Officer of Qritive, for AI Transforming the future of Cancer diagnosis.

Read More

About Qritive

Qritive, headquartered in Singapore with operations in the US and India, is transforming digital pathology through advanced AI-powered solutions that support cancer diagnosis and improve health outcomes.

By leveraging cutting-edge deep learning technology, Qritive supports pathologists in the interpretation of pathology assessments and enhances pathology workflows—enabling faster, more accurate diagnoses and reducing time to treatment.

Qritive is committed to empowering healthcare professionals around the world with tools that promote collaboration and high performance, regardless of complexity or distance.

Get in Touch

Want to learn more about our solutions or explore potential collaborations?

Visit www.qritive.com or contact us at info@qritive.com